Overview
Spastic paraplegia-facial-cutaneous lesions syndrome is an extremely rare genetic condition that combines problems with the nervous system and the skin. The hallmark features include progressive stiffness and weakness in the legs (called spastic paraplegia), distinctive facial features, and skin abnormalities such as unusual lesions or markings on the skin. The leg stiffness happens because of damage to the nerve fibers in the spinal cord that control movement, making walking increasingly difficult over time. This syndrome typically becomes apparent in early childhood, when parents may notice that their child has difficulty walking, stiff legs, or unusual skin findings. Facial features may include a broad forehead or other subtle differences. Some affected individuals may also experience intellectual disability or developmental delays, though the severity can vary from person to person. Because this condition is so rare, there is no specific cure or targeted treatment available. Management focuses on relieving symptoms and improving quality of life. Physical therapy, medications to reduce muscle stiffness (such as baclofen or tizanidine), and dermatological care for skin lesions are the main approaches. Orthopedic interventions may also be needed as the disease progresses. A team of specialists working together provides the best care for affected individuals.
Also known as:
Key symptoms:
Progressive leg stiffness and spasticityDifficulty walking or abnormal gaitWeakness in the legsSkin lesions or unusual skin markingsDistinctive facial featuresIntellectual disability or learning difficultiesDevelopmental delaysIncreased muscle tone in the lower limbsExaggerated reflexes in the legsPossible speech difficultiesBalance problems
Clinical phenotype terms (9)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Spastic paraplegia-facial-cutaneous lesions syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Spastic paraplegia-facial-cutaneous lesions syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Spastic paraplegia-facial-cutaneous lesions syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Spastic paraplegia-facial-cutaneous lesions syndrome.
Community
No community posts yet. Be the first to share your experience with Spastic paraplegia-facial-cutaneous lesions syndrome.
Start the conversation →Latest news about Spastic paraplegia-facial-cutaneous lesions syndrome
No recent news articles for Spastic paraplegia-facial-cutaneous lesions syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is the expected progression of my child's leg stiffness and mobility?,Should we pursue genetic testing, and what type would be most informative?,What therapies are most important to start right away?,Are there any medications that could help with the spasticity?,How should we manage the skin lesions, and when should we be concerned?,Are there any clinical trials or research studies we could participate in?,What school or workplace accommodations should we request?
Common questions about Spastic paraplegia-facial-cutaneous lesions syndrome
What is Spastic paraplegia-facial-cutaneous lesions syndrome?
Spastic paraplegia-facial-cutaneous lesions syndrome is an extremely rare genetic condition that combines problems with the nervous system and the skin. The hallmark features include progressive stiffness and weakness in the legs (called spastic paraplegia), distinctive facial features, and skin abnormalities such as unusual lesions or markings on the skin. The leg stiffness happens because of damage to the nerve fibers in the spinal cord that control movement, making walking increasingly difficult over time. This syndrome typically becomes apparent in early childhood, when parents may notice
How is Spastic paraplegia-facial-cutaneous lesions syndrome inherited?
Spastic paraplegia-facial-cutaneous lesions syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Spastic paraplegia-facial-cutaneous lesions syndrome typically begin?
Typical onset of Spastic paraplegia-facial-cutaneous lesions syndrome is childhood. Age of onset can vary across affected individuals.